JPRN-UMIN000006742已完成2 期
Efficacy and Safety study of adjuvant therapy with capecitabine plus oxaliplatin (XELOX) for the Japanese patient with Stage III curative resection Colon cancer -Phase II study - Efficacy and Safety study of adjuvant therapy with XELOX for the Japanese patient with StageIII curative resection Colon cancer
Multicenter Study Group of Osaka (MCSGO), Colorectal Cancer Treatment Group0 个研究点目标入组 195 人开始时间: 2011年11月20日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 195
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Present with diarrhea 2) synchronous or metachronous (within 5 years) malignancy other than carcinoma in situ 3) CTCAE v4.0>Grade1 of peripheral neuropathy 4) regular use of insulin 5) uncontrollable congestive heart failure, angina,hypertension, arrhythmia 6) Severe mental disease 7) active infection 8) Pregnant or breast-feeding women 9) Woman might be pregnant 10) Inadequate physical condition, as diagnosed by primary physician
研究者
相似试验
已完成
早期 1 期
The Effectiveness of the adjuvant treatment with a compound of sedge plant, saffron and honey to conventional treatment for improvement of cognitive performance of patients with dementiaIRCT2016101030255N1Vice Chancellor for research of Isfahan University of Medical Sciences60
招募中
不适用
Clinical efficacy study of neoadjuvant therapy with intensity-modulated radiotherapy combined with S-1 for resectable pancreatic cancerpancreatic cancerJPRN-UMIN000046456Kyoto Katsura Hospital40
进行中（未招募）
1 期
Evaluation of the benefit of using hydroxychloroquine for uncomplicated term pregnancy in patients with primary obstetric antiphospholipid syndromePrimary obstetrical antiphospholipid syndromeMedDRA version: 20.0Level: PTClassification code 10002817Term: Antiphospholipid syndromeSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2017-004866-86-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)110
已完成
不适用
The phase I/II study of the adjuvant therapy using alpha-galactosylceramide pulsed dendritic cells for patients with advanced high-grade salivary gland tumor followed by standard therpies.Salivary gland tumorJPRN-UMIN000024669Chiba University Hospital6
已完成
1 期
The phase I/II study of the adjuvant therapy using alpha-galactosylceramide pulsed antigen presenting cells for patients with high-grade salivary grand tumor followed by standard therpies.High-grade salivary grand tumorJPRN-UMIN000011509Department of Otorynolaryngology, Head and Neck Surgery, Graduate School of Medicine, Chiba University9